About Pentavalent
Pentavalent is a company based in Bengaluru (India) founded in 2015 by Bhavani PV and Soumya Paul. Pentavalent has raised $40.82 thousand across 2 funding rounds from investors including Bioinnovation Centre and Startup Karnataka. Pentavalent offers products and services including Antibodies, Antigens, Cytokines, and Enzymes. Pentavalent operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Chimerix, HOOKIPA Pharma and Novavax, among others.
- Headquarter Bengaluru, India
- Founders Bhavani PV, Soumya Paul
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pentavalent Bio Sciences Private Limited
- Date of Incorporation 24 Feb, 2015
- Jurisdiction Bangaluru, Karnataka, India
-
Annual Revenue
$241.41 K (USD)356.01as on Mar 31, 2023
-
Net Profit
$20.74 K (USD)300.13as on Mar 31, 2023
-
EBITDA
$31.07 K (USD)222.19as on Mar 31, 2023
-
Total Equity Funding
$40.82 K (USD)
in 2 rounds
-
Latest Funding Round
$40.82 K (USD), Seed
Oct 19, 2020
-
Investors
Bioinnovation Centre
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pentavalent
Pentavalent offers a comprehensive portfolio of products and services, including Antibodies, Antigens, Cytokines, and Enzymes.
Monoclonal antibodies for precise IVD testing applications
Recombinant proteins tailored for diagnostics and research
Signaling proteins for immune response diagnostics
Purified enzymes for IVD and health applications
Funding Insights of Pentavalent
Pentavalent has successfully raised a total of $40.82K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $40.82 thousand completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pentavalent
Pentavalent has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Bioinnovation Centre and Startup Karnataka.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Govt backed startup incubator focused on the Life Science sector
|
Locked | Locked | Locked | |
|
Support for startups in Karnataka is delivered through policies, funding, and networking services.
|
Locked | Locked | Locked |
Investor details for Pentavalent
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pentavalent
Investment portfolio details for Pentavalent
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pentavalent
Detailed financials for Pentavalent
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pentavalent Comparisons
Peer comparison for Pentavalent
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pentavalent
Pentavalent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Chimerix, HOOKIPA Pharma and Novavax, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| Locked | Locked | Locked |
Antiviral oral therapeutics are developed for infectious diseases and cancers.
|
|
| Locked | Locked | Locked |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| Locked | Locked | Locked |
Novel vaccines are developed using nanoparticle and matrix adjuvant technology.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
Detailed competitors of Pentavalent
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pentavalent
Complete news archive for Pentavalent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pentavalent
Pentavalent was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Pentavalent is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Pentavalent is a funded company, having raised a total of $40.82K across 2 funding rounds to date.
Annual revenue of Pentavalent is $241.41K as on Mar 31, 2023.
Pentavalent was founded in 2015 in Bengaluru, India, within the biotechnology sector. Research services are delivered in proteomics, genomics, molecular techniques, antibody generation, microbial studies, cell culture, computational assistance, and preclinical areas. Vaccines and diagnostics for infectious diseases are developed as part of core operations.
Pentavalent's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
Pentavalent offers Antibodies, Antigens, Cytokines, and Enzymes.
Pentavalent has 2 investors. Key investors include Bioinnovation Centre, and Startup Karnataka.
The valuation of Pentavalent is $806.3K as of Oct 2020.